4006-776-356 出国就医服务电话

免费获得国外相关药品,最快 1 个工作日回馈药物信息

出境医 / 临床实验 / PMCF Neo Pedicle Screw and Cage Systems

PMCF Neo Pedicle Screw and Cage Systems

Study Description
Brief Summary:
The objectives of this clinical observational study is to evaluate the safety and efficacy (performance) of the Neo Pedicle Screw System™ and the Neo Cage System™ interbody fusion device. To demonstrate non-inferiority of safety and function to an historical control from the published medical literature on competitive devices.

Condition or disease Intervention/treatment
Degenerative Disc Disease Spondylolisthesis Spinal Stenosis Spinal Tumor Trauma Pseudoarthrosis of Spine Device: NEO Pedicle Screw System™ Device: Neo Cage System™

Study Design
Layout table for study information
Study Type : Observational
Estimated Enrollment : 150 participants
Observational Model: Cohort
Time Perspective: Other
Official Title: Fusion With the Neo Pedicle Screw and Cage Systems: A Post Market Clinical Follow-up Study
Actual Study Start Date : October 15, 2019
Estimated Primary Completion Date : July 2023
Estimated Study Completion Date : July 2023
Arms and Interventions
Group/Cohort Intervention/treatment
Pedicle screw system alone Device: NEO Pedicle Screw System™
The NEO Pedicle Screw System™ is intended to provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion.

Pedicle screw system with cages Device: NEO Pedicle Screw System™
The NEO Pedicle Screw System™ is intended to provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion.

Device: Neo Cage System™
Neo Cage System™ is intended to be used with bone graft material to facilitate interbody fusion and to be used with the NEO Pedicle Screw System™

Outcome Measures
Primary Outcome Measures :
  1. Change in patient´s function from baseline to 12 months [ Time Frame: 12 months ]
    Clinical outcome in function as measured by the 100 point Oswestry Disability Index (ODI). Zero is equated with no disability and 100 is the maximum disability possible.

  2. The rate of cage migration in cage-plus-screw systems. [ Time Frame: 12 months and 24 months post operatively ]
    Defined as posterior movement of the cage past the posterior wall of the vertebral body.

  3. The rate of pedicle screw loosening in screw only and cage-plus-screw systems. [ Time Frame: 12 months and 24 months post operatively ]
    A radiolucent zone, >1mm, surrounding the pedicle screw seen in radiograhs


Eligibility Criteria
Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
In total, approximately 150 patients will be recruited and enrolled to ensure that at least 132 patients are evaluable at 12 and 24 months. Patients are recruited consecutively, retrospectively as well as prospectively. The potential patients to be recruited have either already been implanted or are planned to be implanted with the Neo Pedicle Screw System (Arm 1) or Neo Cage System and Neo Pedicle Screw System (Arm 2).
Criteria

Inclusion criteria:

  • Patient has undergone or is intended to undergo surgery with the Neo Pedicle Screw System™, standalone or in combination with the Neo Cage System™, for any of the approved indications as defined in the respective labelling
  • Patient has participated in or is willing to participate in the routine postoperative follow-up program
  • Patient is willing to provide written informed consent

Exclusion criteria:

  • Patient is under the age of 18 or skeletally immature
  • Patient had or has a contraindication to surgery or to any of the implant systems used in the study, as defined in the respective labelling
Contacts and Locations

Contacts
Layout table for location contacts
Contact: ingrid Moberg, DDS +46 725 45 35 29 ingrid.moberg@neo-medical.com

Locations
Layout table for location information
Germany
Dep. of Neurosurgery, Nordwest Krankenhaus Sanderbusch Recruiting
Sande, Germany, 26452
Contact: Yasser Abdalla, MD    +49 162 2018181    y.abdalla@sanderbusch.de   
Spain
Spine Center, University Hospital Valladolid Recruiting
Valladolid, Spain, 47006
Contact: David C Noriega, PhD, MD    +34 630 381 468    noriega1970@icloud.com   
Sponsors and Collaborators
Neo Medical SA
ConfinisCPM
Investigators
Layout table for investigator information
Principal Investigator: David C Noriega, PhD, MD Spine Center, University Hospital Valladolid, Valladolid, Spain
Principal Investigator: Yasser Abdalla, MD Dep. of Neurosurgery, Nordwest Krankenhaus Sanderbusch, Sande, Germany
Tracking Information
First Submitted Date May 16, 2019
First Posted Date May 20, 2019
Last Update Posted Date March 3, 2021
Actual Study Start Date October 15, 2019
Estimated Primary Completion Date July 2023   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: May 20, 2019)
  • Change in patient´s function from baseline to 12 months [ Time Frame: 12 months ]
    Clinical outcome in function as measured by the 100 point Oswestry Disability Index (ODI). Zero is equated with no disability and 100 is the maximum disability possible.
  • The rate of cage migration in cage-plus-screw systems. [ Time Frame: 12 months and 24 months post operatively ]
    Defined as posterior movement of the cage past the posterior wall of the vertebral body.
  • The rate of pedicle screw loosening in screw only and cage-plus-screw systems. [ Time Frame: 12 months and 24 months post operatively ]
    A radiolucent zone, >1mm, surrounding the pedicle screw seen in radiograhs
Original Primary Outcome Measures
 (submitted: May 16, 2019)
  • To evaluate the efficacy (performance) of the Neo Pedicle Screw System™ and the Neo Cage system™. [ Time Frame: 24 months post operative ]
    To demonstrate non-inferiority of function as measured by the 100-point Oswestry Disability Index (ODI) to an historical control from the published medical literature on competitive devices.
  • To evaluate the safety of the Neo Pedicle Screw System™ and the Neo Cage system™. [ Time Frame: 24 months post operative ]
    For safety, the rate of pedicle screw loosening and cage migration will be compared to published results of other state-of-the-art stabilization systems.
Change History
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title PMCF Neo Pedicle Screw and Cage Systems
Official Title Fusion With the Neo Pedicle Screw and Cage Systems: A Post Market Clinical Follow-up Study
Brief Summary The objectives of this clinical observational study is to evaluate the safety and efficacy (performance) of the Neo Pedicle Screw System™ and the Neo Cage System™ interbody fusion device. To demonstrate non-inferiority of safety and function to an historical control from the published medical literature on competitive devices.
Detailed Description Not Provided
Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Other
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population In total, approximately 150 patients will be recruited and enrolled to ensure that at least 132 patients are evaluable at 12 and 24 months. Patients are recruited consecutively, retrospectively as well as prospectively. The potential patients to be recruited have either already been implanted or are planned to be implanted with the Neo Pedicle Screw System (Arm 1) or Neo Cage System and Neo Pedicle Screw System (Arm 2).
Condition
  • Degenerative Disc Disease
  • Spondylolisthesis
  • Spinal Stenosis
  • Spinal Tumor
  • Trauma
  • Pseudoarthrosis of Spine
Intervention
  • Device: NEO Pedicle Screw System™
    The NEO Pedicle Screw System™ is intended to provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion.
  • Device: Neo Cage System™
    Neo Cage System™ is intended to be used with bone graft material to facilitate interbody fusion and to be used with the NEO Pedicle Screw System™
Study Groups/Cohorts
  • Pedicle screw system alone
    Intervention: Device: NEO Pedicle Screw System™
  • Pedicle screw system with cages
    Interventions:
    • Device: NEO Pedicle Screw System™
    • Device: Neo Cage System™
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Recruiting
Estimated Enrollment
 (submitted: May 16, 2019)
150
Original Estimated Enrollment Same as current
Estimated Study Completion Date July 2023
Estimated Primary Completion Date July 2023   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion criteria:

  • Patient has undergone or is intended to undergo surgery with the Neo Pedicle Screw System™, standalone or in combination with the Neo Cage System™, for any of the approved indications as defined in the respective labelling
  • Patient has participated in or is willing to participate in the routine postoperative follow-up program
  • Patient is willing to provide written informed consent

Exclusion criteria:

  • Patient is under the age of 18 or skeletally immature
  • Patient had or has a contraindication to surgery or to any of the implant systems used in the study, as defined in the respective labelling
Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts
Contact: ingrid Moberg, DDS +46 725 45 35 29 ingrid.moberg@neo-medical.com
Listed Location Countries Germany,   Spain
Removed Location Countries  
 
Administrative Information
NCT Number NCT03956537
Other Study ID Numbers NeoPMCF01
Has Data Monitoring Committee Not Provided
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party Neo Medical SA
Study Sponsor Neo Medical SA
Collaborators ConfinisCPM
Investigators
Principal Investigator: David C Noriega, PhD, MD Spine Center, University Hospital Valladolid, Valladolid, Spain
Principal Investigator: Yasser Abdalla, MD Dep. of Neurosurgery, Nordwest Krankenhaus Sanderbusch, Sande, Germany
PRS Account Neo Medical SA
Verification Date March 2021